Literature DB >> 9631837

Familial amyloid polyneuropathy type I (Portuguese): distribution and characterization of renal amyloid deposits.

L Lobato1, I Beirão, S M Guimarães, D Droz, S Guimarães, J P Grünfeld, L H Noël.   

Abstract

Renal amyloidosis has been considered rare and late in the evolution of the transthyretin (TTR) familial amyloid polyneuropathy (FAP) of the Portuguese type (type I). Renal biopsy has been performed systematically in 14 patients with FAP type I before liver transplantation. In all patients, TTR Met30 mutation was shown. Seven had proteinuria or abnormal microalbuminuria, whereas seven others had no urinary abnormalities. All had renal amyloid deposition predominantly in the medulla. Glomerular and vascular involvement was more prominent in patients with urinary abnormalities. Patients with the most extensive renal lesions represented a subgroup with a low score of polyneuropathy disability, a high prevalence of nephropathy in the proband generation, or a late onset for relatives with nephropathy. Immunohistochemistry studies showed that the amyloid substance corresponded to transthyretin. We have shown that renal TTR-derived amyloid deposition is common in patients with FAP type I, even in the absence of urinary abnormalities. The clinical presentation of nephropathy is not a late occurrence in the disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9631837     DOI: 10.1053/ajkd.1998.v31.pm9631837

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

1.  Evidence of the presence of amyloid substance in the blood of familial amyloidotic polyneuropathy patients with ATTR Val30Met mutation.

Authors:  Jinping Liu; Jie Lan; Peng Zhao; Fang Zheng; Jingjing Song; Peilan Zhang; Xuguo Sun
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 2.  Transthyretin (TTR) cardiac amyloidosis.

Authors:  Frederick L Ruberg; John L Berk
Journal:  Circulation       Date:  2012-09-04       Impact factor: 29.690

Review 3.  Amyloid nephropathy.

Authors:  Mazdak A Khalighi; W Dean Wallace; Miguel F Palma-Diaz
Journal:  Clin Kidney J       Date:  2014-03-13

Review 4.  Dialysis-related amyloidosis: challenges and solutions.

Authors:  R Scarpioni; M Ricardi; V Albertazzi; S De Amicis; F Rastelli; L Zerbini
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-12-07

5.  Transthyretin-related hereditary amyloidosis with recurrent vomiting and renal insufficiency as the initial presentation: A case report.

Authors:  Jing Xu; Meng Yang; Xiaoxia Pan; Xialian Yu; Jingyuan Xie; Hong Ren; Xiao Li; Nan Chen
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

6.  Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients.

Authors:  Justine Solignac; Emilien Delmont; Etienne Fortanier; Shahram Attarian; Julien Mancini; Laurent Daniel; Ioana Ion; Jean-Etienne Ricci; Thomas Robert; Gilbert Habib; Olivier Moranne; Noémie Jourde-Chiche
Journal:  Clin Kidney J       Date:  2022-05-05

Review 7.  Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.

Authors:  David Adams; Yukio Ando; João Melo Beirão; Teresa Coelho; Morie A Gertz; Julian D Gillmore; Philip N Hawkins; Isabelle Lousada; Ole B Suhr; Giampaolo Merlini
Journal:  J Neurol       Date:  2020-01-06       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.